Status:
ENROLLING_BY_INVITATION
Efficacy and Safety of DTG/3TC in Treatment-naïve HIV-1 Infected Patients
Lead Sponsor:
Chungnam National University Hospital
Conditions:
HIV
Eligibility:
All Genders
19+ years
Brief Summary
Non-interventional, retrospective, single arm study of individuals who have initiated a DTG/3TC regimen. Medical chart will be reviewed by the investigators. Naive subjects will be identified by the c...
Eligibility Criteria
Inclusion
- HIV-1 diagnosis
- Prescribed DTG/3TC alone to manage HIV-1 infection as initial antiretroviral treatment at the study centers
Exclusion
- HIV-2 diagnosis
- Previous antiretroviral treatment
Key Trial Info
Start Date :
January 24 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 30 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06928090
Start Date
January 24 2025
End Date
January 30 2027
Last Update
April 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chungnam National University Hospital, 282 Munwha-ro
Daejeon, South Korea, 35015